Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center Prospective Measurement of Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus™

NCT03562975 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT03562975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center Prospective Measurement of Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus™
Lead sponsor
University of South Florida
Phase
Observational
Overall status
Completed
Start date
July 23, 2018
Completion date
January 11, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, demyelinating diseases, immune system diseases, multiple sclerosis, nervous system diseases, pathologic processes, primary progressive multiple sclerosis, relapsing remitting multiple sclerosis